Cellectar, which designs and develops products to detect, treat, and monitor human cancers, has named Ernest Allen as director of clinical operations and Lisa Ann Trembath as manager of medical affairs. The appointments come as Cellectar moves its lead drug candidate toward clinical trials....
The Wisconsin Alumni Research Foundation has filed amendments with the U.S. Patent and Trademark Office to make technical changes to the claims of its three human embryonic stem cell patents. WARF said the technical language submitted to PTO examiners more clearly differentiates the University of...
TomoTherapy executives prefer investors to take the long view of their financial performance, but the company's projected third quarter performance is nothing to scoff at. The Madison based medical device manufacturer has revised its third quarter projections, which indicate a 61 percent increase in anticipated...
From angel capital to finding the right mix of executive and scientific talent, Wisconsin technology and biotechnology start ups have many needs in their attempts to transfer technology from gown to town. The University of Wisconsin-Madison has established an Office of Corporate Relations to serve...
Centrose, LLC, a Madison biopharmaceutical company, will receive an additional $160,000 from the National Cancer Institute to develop more effective anti-cancer drugs. Among the projects the new grant will support is the role the company's sugar enhancement technology can play in treating non-small cell lung...
Investors flocked to Milwaukee this week for the BIO Mid-America VentureForum and had some promising things to say about the future of venture capital deployment in Wisconsin. Rather than dwelling on any one state or quarterly period, they recommend tracking success over the entire region...
The National Institute of Environmental Health Sciences has awarded Madison's Platypus Technologies with a $600,000 grant to help develop a new environmental sensor. The project, which will be done in collaboration with the Boeing Co., will produce a sensor that helps researchers assess the role...
The Japanese government has a strong commitment to its biotech industry, which has aided the second largest pharma market in the world. Yet Japanese Big Pharma doesn't seem to be paying a lot of attention to it, if the recent BIO-Japan conference is any indication,...
After receiving a $7.2 million grant from the National Institutes of Health, a team of researchers from the University of Wisconsin-Madison will explore the potential of stem cells to treat Lou Gehrig's disease. The team will be led by noted stem cell researcher Clive Svendsen....
As it approaches an all-important presentation to investment funds at the BIO Mid-America VentureForum, Madison's Centrose, LLC has received an $875,000 funding commitment from the State Department of Financial Institutions. The company, which is developing drug therapies based on proprietary sugar chemistries, is seeking a...